NR2E3 (Q9Y5X4) variants and mutations
NR2E3 (also known as Q9Y5X4) is a human protein-coding gene encoding a photoreceptor-specific nuclear receptor protein. It directs rod-photoreceptor differentiation while repressing inappropriate cone gene programs during retinal development. Pathogenic variants cause enhanced S-cone syndrome, retinitis pigmentosa, and related inherited retinal dystrophies. This analysis covers 865 NR2E3 variants and mutations. Of these, 86% have computational variant effect predictions. Disease context includes enhanced S-cone syndrome, retinitis pigmentosa 37, and retinitis pigmentosa. Example NR2E3 variants include M1K, M1R, and M1T.
Variant analysis overview
- Gene: NR2E3
- Protein: Q9Y5X4
- UniProt accession: Q9Y5X4
- Organism: Homo sapiens
- Variants analyzed: 865
- Variant scope: all variants
- Completed: 2026-08-22
Variant and mutation evidence
- Variant composition: 595 unspecified-consequence records; 161 missense variants; 8 stop-gained variants; 74 synonymous variants; 12 frameshift variants; 6 in-frame deletions; 4 splice-region variants; 1 in-frame insertions; 6 substitution
- Prediction scores: 744 variants have prediction scores (86% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: enhanced S-cone syndrome, retinitis pigmentosa 37, retinitis pigmentosa, Goldmann-Favre syndrome, Retinal dystrophy, Joubert syndrome and related disorders, Cone rod dystrophy, cone-rod dystrophy, retinal disorder, autosomal recessive retinitis pigmentosa, hereditary disease, inherited retinal dystrophy.
Protein structure and variant hotspots
- Protein features: 1 domains.
- Structural context: 332 variants have structural context.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, Interaction Network Analysis, Protein Data Bank, AlphaFold DB, gnomAD constraint, Open Targets, ClinGen, MaveDB, LitVar.
Notable NR2E3 variants
Examples include M1K, M1R, M1T, E2D, E2G, E2Q, E2K, E2*. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- M1K (p.Met1Lys), rs975791531, ClinGen CA393031309, ClinVar RCV001896166, MetaLR 0.10, MetaSVM -0.96, Uncertain significance, not provided
- M1R (p.Met1Arg), rs975791531, ClinGen CA272574434, ClinVar RCV001212550, ClinVar RCV001828694, MetaLR 0.10, MetaSVM -0.96, Uncertain significance, not provided
- M1T (p.Met1Thr), rs975791531, ClinGen CA393031311, ClinVar RCV003078038, MetaLR 0.10, MetaSVM -0.96, Uncertain significance, not provided
- E2D (p.Glu2Asp), gnomAD rs1432485654, CADD 0.06, PolyPhen-2 0.00
- E2G (p.Glu2Gly), rs2543251941, ClinGen CA393031334, ClinVar RCV003850818, Uncertain significance, not provided
- E2Q (p.Glu2Gln), Ensembl rs2140287768
- E2K (p.Glu2Lys), gnomAD 15-71810747-G-A, CADD 0.01, PolyPhen-2 0.00
- E2* (p.Glu2Ter), gnomAD 15-71810747-G-T, CADD 23.20
- T3N (p.Thr3Asn), TOPMed rs1159703115, gnomAD rs1159703115, CADD 0.46, PolyPhen-2 0.08
- T3S (p.Thr3Ser), TOPMed rs1159703115, gnomAD rs1159703115, CADD 0.62
- T3I (p.Thr3Ile), gnomAD 15-71810751-C-T, CADD 7.49, PolyPhen-2 0.16
- T3T (p.Thr3Thr), gnomAD 15-71810752-C-A, CADD 0.35
- R4K (p.Arg4Lys), rs1417303545, ClinGen CA393031364, ClinVar RCV002996395, ClinVar RCV005685080, CADD 12.10, PolyPhen-2 0.01, Uncertain significance, Inborn genetic diseases; not provided
- R4S (p.Arg4Ser), NCI-TCGA TCGA novel, Ensembl rs1595955332, Variant assessed as somatic; moderate impact.
- R4* (p.Arg4Ter), gnomAD 15-71810753-A-T, CADD 23.80
- R4G (p.Arg4Gly), gnomAD 15-71810753-A-G, CADD 3.32, PolyPhen-2 0.00
- R4I (p.Arg4Ile), gnomAD 15-71810754-G-T, CADD 17.10, PolyPhen-2 0.00
- R4R (p.Arg4Arg), gnomAD 15-71810755-A-G, CADD 2.07
- P5S (p.Pro5Ser), TOPMed rs2054171550, CADD 1.74, PolyPhen-2 0.14
- P5T (p.Pro5Thr), gnomAD 15-71810756-C-A, CADD 1.13, PolyPhen-2 0.11
- P5L (p.Pro5Leu), gnomAD 15-71810757-C-T, CADD 5.67, PolyPhen-2 0.00
- P5Q (p.Pro5Gln), gnomAD 15-71810757-C-A, CADD 11.70, PolyPhen-2 0.28
- P5P (p.Pro5Pro), gnomAD 15-71810758-A-G, CADD 0.31
- T6A (p.Thr6Ala), gnomAD 15-71810759-A-G, CADD 0.61, PolyPhen-2 0.00
- T6I (p.Thr6Ile), gnomAD 15-71810760-C-T, CADD 0.74, PolyPhen-2 0.10
- T6R (p.Thr6Arg), gnomAD 15-71810760-C-G, CADD 2.74, PolyPhen-2 0.21
- T6K (p.Thr6Lys), gnomAD 15-71810760-C-A, CADD 3.17, PolyPhen-2 0.06
- T6T (p.Thr6Thr), gnomAD 15-71810761-A-T, CADD 0.80
- A7T (p.Ala7Thr), Ensembl rs1595955336
- A7S (p.Ala7Ser), gnomAD 15-71810762-G-T, CADD 6.33, PolyPhen-2 0.09
- A7D (p.Ala7Asp), gnomAD 15-71810763-C-A, CADD 10.90, PolyPhen-2 0.31
- A7A (p.Ala7Ala), rs1365738203, gnomAD 15-71810764-T-C, CADD 0.55
- L8P (p.Leu8Pro), rs2054171599, ClinGen CA393031419, ClinVar RCV001233330, Ensembl rs2054171599, CADD 2.56, PolyPhen-2 0.00, Uncertain significance, not provided
- L8L (p.Leu8Leu), gnomAD 15-71810765-C-T, CADD 2.90
- L8M (p.Leu8Met), gnomAD 15-71810765-C-A, CADD 6.91, PolyPhen-2 0.04
- L8R (p.Leu8Arg), gnomAD 15-71810766-T-G, CADD 2.88, PolyPhen-2 0.00
- M9R (p.Met9Arg), ESP rs374232020, ExAC rs374232020, TOPMed rs374232020, gnomAD rs374232020, CADD 13.30, PolyPhen-2 0.01
- M9V (p.Met9Val), gnomAD rs2054171654, CADD 2.03, PolyPhen-2 0.00
- M9T (p.Met9Thr), gnomAD 15-71810769-T-C, CADD 3.12, PolyPhen-2 0.00
- M9I (p.Met9Ile), gnomAD 15-71810770-G-T, CADD 11.20, PolyPhen-2 0.00
- S10R (p.Ser10Arg), Ensembl rs868419675, CADD 15.50, PolyPhen-2 0.35
- S10A (p.Ser10Ala), gnomAD 15-71810770-GA-G, CADD 21.70
- S10C (p.Ser10Cys), gnomAD 15-71810771-A-T, CADD 22.40, PolyPhen-2 0.61
- S10G (p.Ser10Gly), gnomAD 15-71810771-A-G, CADD 17.40, PolyPhen-2 0.00
- S10I (p.Ser10Ile), gnomAD 15-71810772-G-T, CADD 13.50, PolyPhen-2 0.45
- S10N (p.Ser10Asn), gnomAD 15-71810772-G-A, CADD 14.70, PolyPhen-2 0.08
- S10S (p.Ser10Ser), gnomAD 15-71810773-C-T, CADD 6.14
- S11A (p.Ser11Ala), rs2054171751, ClinGen CA393031462, ClinVar RCV003842357, Ensembl rs2054171751, CADD 14.10, PolyPhen-2 0.00, Uncertain significance, not provided
- S11P (p.Ser11Pro), gnomAD 15-71810774-T-C, CADD 15.90, PolyPhen-2 0.00
- S11Y (p.Ser11Tyr), gnomAD 15-71810775-C-A, CADD 18.60, PolyPhen-2 0.14
- S11S (p.Ser11Ser), rs764469729, gnomAD 15-71810776-C-T, CADD 7.80
- T12I (p.Thr12Ile), Ensembl rs921294165, CADD 8.77, PolyPhen-2 0.02
- T12K (p.Thr12Lys), gnomAD 15-71810778-C-A, CADD 3.41, PolyPhen-2 0.00
- T12R (p.Thr12Arg), gnomAD 15-71810778-C-G, CADD 2.45, PolyPhen-2 0.00
- T12T (p.Thr12Thr), rs1245543498, gnomAD 15-71810779-A-G, CADD 0.82
- V13L (p.Val13Leu), rs1367552026, ClinGen CA393031489, ClinVar RCV001339883, ClinVar RCV001830415, CADD 0.57, PolyPhen-2 0.00, Uncertain significance, not provided
- V13E (p.Val13Glu), gnomAD 15-71810781-T-A, CADD 20.40, PolyPhen-2 0.01
- V13A (p.Val13Ala), gnomAD 15-71810781-T-C, CADD 14.70, PolyPhen-2 0.00
- V13V (p.Val13Val), rs1392532455, gnomAD 15-71810782-G-A, CADD 7.10
- A14T (p.Ala14Thr), NCI-TCGA TCGA novel, CADD 20.80, PolyPhen-2 0.12, Variant assessed as somatic; moderate impact.
- A14S (p.Ala14Ser), gnomAD 15-71810783-G-T, CADD 15.10, PolyPhen-2 0.01
- A14V (p.Ala14Val), gnomAD 15-71810784-C-T, CADD 16.70, PolyPhen-2 0.26
- A14D (p.Ala14Asp), gnomAD 15-71810784-C-A, CADD 21.00, PolyPhen-2 0.30
- A14A (p.Ala14Ala), gnomAD 15-71810785-T-C, CADD 11.90
- A15T (p.Ala15Thr), Ensembl rs2054171943, CADD 17.40, PolyPhen-2 0.01
- A15S (p.Ala15Ser), gnomAD 15-71810786-G-T, CADD 15.80, PolyPhen-2 0.12
- A15E (p.Ala15Glu), gnomAD 15-71810787-C-A, CADD 20.60, PolyPhen-2 0.45
- A15G (p.Ala15Gly), gnomAD 15-71810787-C-G, CADD 20.80, PolyPhen-2 0.26
- A15V (p.Ala15Val), gnomAD 15-71810787-C-T, CADD 21.20, PolyPhen-2 0.01
- A15A (p.Ala15Ala), rs752130237, gnomAD 15-71810788-A-G, CADD 6.68
- A16P (p.Ala16Pro), TOPMed rs2054172010, Uncertain significance, Inborn genetic diseases
- A16V (p.Ala16Val), rs1239436868, ClinGen CA393031542, ClinVar RCV001279039, gnomAD rs1239436868, CADD 16.80, PolyPhen-2 0.04, Uncertain significance, Goldmann-Favre syndrome
- A16S (p.Ala16Ser), gnomAD 15-71810789-G-T, CADD 4.83, PolyPhen-2 0.03
- A16D (p.Ala16Asp), gnomAD 15-71810790-C-A, CADD 16.80, PolyPhen-2 0.11
- A16A (p.Ala16Ala), gnomAD 15-71810791-T-A, CADD 7.98
- A17S (p.Ala17Ser), gnomAD rs1361799339, CADD 8.58, PolyPhen-2 0.01
- A17V (p.Ala17Val), rs534483995, ClinGen CA7640178, cosmic curated COSV58907, ClinVar RCV001049194, CADD 1.84, PolyPhen-2 0.00, Conflicting interpretations, Inborn genetic diseases; not provided
- p.Ala17 Ala20del, rs1309775709, gnomAD 15-71810783-GCTGC, CADD 14.50
- A17T (p.Ala17Thr), gnomAD 15-71810792-G-A, CADD 11.70, PolyPhen-2 0.00
- A17E (p.Ala17Glu), gnomAD 15-71810793-C-A, CADD 0.17, PolyPhen-2 0.04
- A17A (p.Ala17Ala), rs753463414, gnomAD 15-71810794-G-A, CADD 1.82
- P18H (p.Pro18His), cosmic curated COSV58907, ExAC rs778754527, gnomAD rs778754527, CADD 22.60, PolyPhen-2 0.61
- P18L (p.Pro18Leu), ExAC rs778754527, gnomAD rs778754527, CADD 20.20, PolyPhen-2 0.19
- P18R (p.Pro18Arg), ExAC rs778754527, gnomAD rs778754527, CADD 19.90
- P18S (p.Pro18Ser), rs754661615, ClinGen CA7640180, cosmic curated COSV10522, ClinVar RCV003081110, CADD 12.90, PolyPhen-2 0.00, Uncertain significance, Inborn genetic diseases; not provided
- P18T (p.Pro18Thr), gnomAD 15-71810795-C-A, CADD 15.70, PolyPhen-2 0.01
- P18P (p.Pro18Pro), gnomAD 15-71810797-T-A, CADD 0.59
- A19T (p.Ala19Thr), gnomAD 15-71810798-G-A, CADD 8.72, PolyPhen-2 0.00
- A19S (p.Ala19Ser), gnomAD 15-71810798-G-T, CADD 7.71, PolyPhen-2 0.00
- A19E (p.Ala19Glu), gnomAD 15-71810799-C-A, CADD 8.36, PolyPhen-2 0.04
- A19V (p.Ala19Val), gnomAD 15-71810799-C-T, CADD 8.97, PolyPhen-2 0.00
- A19A (p.Ala19Ala), gnomAD 15-71810800-A-G, CADD 0.59
- A20V (p.Ala20Val), TOPMed rs1437279949, gnomAD rs1437279949, CADD 8.12, PolyPhen-2 0.00
- A20T (p.Ala20Thr), gnomAD 15-71810801-G-A, CADD 1.01, PolyPhen-2 0.00
- A20S (p.Ala20Ser), gnomAD 15-71810801-G-T, CADD 0.58, PolyPhen-2 0.00
- A20D (p.Ala20Asp), gnomAD 15-71810802-C-A, CADD 6.54, PolyPhen-2 0.08
- A20G (p.Ala20Gly), gnomAD 15-71810802-C-G, CADD 7.51, PolyPhen-2 0.02
- A20A (p.Ala20Ala), rs1177404834, gnomAD 15-71810803-T-C, CADD 0.79
- G21E (p.Gly21Glu), rs1385496653, ClinGen CA393031609, ClinVar RCV003321131, TOPMed rs1385496653, CADD 7.74, PolyPhen-2 0.04, Uncertain significance, not provided
- G21W (p.Gly21Trp), gnomAD 15-71810804-G-T, CADD 18.50, PolyPhen-2 0.29
- G21R (p.Gly21Arg), gnomAD 15-71810804-G-A, CADD 13.50, PolyPhen-2 0.06
- G21V (p.Gly21Val), gnomAD 15-71810805-G-T, CADD 1.57, PolyPhen-2 0.00
- G21G (p.Gly21Gly), gnomAD 15-71810806-G-A, CADD 2.67
- A22T (p.Ala22Thr), TOPMed rs1426117947, gnomAD rs1426117947, CADD 2.35, PolyPhen-2 0.00, Uncertain significance, Inborn genetic diseases
- A22D (p.Ala22Asp), gnomAD 15-71810808-C-A, CADD 13.30, PolyPhen-2 0.03
- A22V (p.Ala22Val), gnomAD 15-71810808-C-T, CADD 12.80, PolyPhen-2 0.03
- A22G (p.Ala22Gly), gnomAD 15-71810808-C-G, CADD 13.70, PolyPhen-2 0.00
- A22A (p.Ala22Ala), rs1162219397, gnomAD 15-71810809-T-G, CADD 2.32
- A23P (p.Ala23Pro), rs771928643, ClinGen CA7640183, ClinVar RCV001062402, ClinVar RCV001275368, CADD 15.10, PolyPhen-2 0.15, Uncertain significance, not provided; Enhanced S-cone syndrome; Retinitis pigmentosa 37
- A23V (p.Ala23Val), gnomAD rs1462813894, CADD 9.64, PolyPhen-2 0.00
- A23T (p.Ala23Thr), gnomAD 15-71810810-G-A, CADD 9.04, PolyPhen-2 0.00
- A23S (p.Ala23Ser), gnomAD 15-71810810-G-T, CADD 12.90, PolyPhen-2 0.00
- A23A (p.Ala23Ala), gnomAD 15-71810812-C-A, CADD 2.85
- S24P (p.Ser24Pro), gnomAD rs1375258734
- S24Y (p.Ser24Tyr), Ensembl rs867438381, CADD 23.00, PolyPhen-2 0.56
- S24F (p.Ser24Phe), gnomAD 15-71810814-C-T, CADD 23.40, PolyPhen-2 0.56
- S24S (p.Ser24Ser), gnomAD 15-71810815-C-T, CADD 7.04
- R25G (p.Arg25Gly), gnomAD 15-71810816-A-G, CADD 19.80, PolyPhen-2 0.00
- R25M (p.Arg25Met), gnomAD 15-71810817-G-T, CADD 20.20, PolyPhen-2 0.32
- R25K (p.Arg25Lys), gnomAD 15-71810817-G-A, CADD 13.90, PolyPhen-2 0.00
- R25R (p.Arg25Arg), gnomAD 15-71810818-G-A, CADD 7.96
- K26Q (p.Lys26Gln), rs373237215, ClinGen CA7640185, ClinVar RCV000915773, ClinVar RCV001275590, CADD 18.40, PolyPhen-2 0.09, Benign, not provided
- K26E (p.Lys26Glu), gnomAD 15-71810819-A-G, CADD 19.20, PolyPhen-2 0.05
- K26N (p.Lys26Asn), gnomAD 15-71810821-G-T, CADD 20.80, PolyPhen-2 0.03
- E27A (p.Glu27Ala), gnomAD rs1385045523, CADD 17.20, PolyPhen-2 0.09
- E27K (p.Glu27Lys), gnomAD rs1315773209, CADD 21.20, PolyPhen-2 0.16
- E27* (p.Glu27Ter), gnomAD 15-71810822-G-T, CADD 36.00
- E27G (p.Glu27Gly), gnomAD 15-71810823-A-G, CADD 19.90, PolyPhen-2 0.00
- E27D (p.Glu27Asp), gnomAD 15-71810824-G-T, CADD 11.70, PolyPhen-2 0.00
- E27E (p.Glu27Glu), rs770924023, gnomAD 15-71810824-G-A, CADD 6.26
- S28F (p.Ser28Phe), TOPMed rs1289412511, gnomAD rs1289412511, CADD 23.20, PolyPhen-2 0.56
- S28T (p.Ser28Thr), rs1036292834, ClinGen CA272574464, ClinVar RCV001905750, ClinVar RCV004041384, CADD 21.20, PolyPhen-2 0.10, Uncertain significance, Inborn genetic diseases; not provided
- S28Y (p.Ser28Tyr), gnomAD 15-71810826-C-A, CADD 22.90, PolyPhen-2 0.56
- S28S (p.Ser28Ser), rs1320961762, gnomAD 15-71810827-T-C, CADD 8.74
- P29S (p.Pro29Ser), gnomAD 15-71810828-C-T, CADD 17.60, PolyPhen-2 0.04
- P29T (p.Pro29Thr), gnomAD 15-71810828-C-A, CADD 17.10, PolyPhen-2 0.23
- P29L (p.Pro29Leu), gnomAD 15-71810829-C-T, CADD 22.90, PolyPhen-2 0.37
- P29P (p.Pro29Pro), gnomAD 15-71810830-A-G, CADD 5.09
- G30R (p.Gly30Arg), ESP rs371396941, TOPMed rs371396941, gnomAD rs371396941, CADD 23.90, PolyPhen-2 0.74
- G30S (p.Gly30Ser), ESP rs371396941, TOPMed rs371396941, gnomAD rs371396941, CADD 18.40, PolyPhen-2 0.07
- G30C (p.Gly30Cys), gnomAD 15-71810831-G-T, CADD 23.10, PolyPhen-2 0.85
- G30D (p.Gly30Asp), gnomAD 15-71810832-G-A, CADD 21.30, PolyPhen-2 0.04
- G30V (p.Gly30Val), gnomAD 15-71810832-G-T, CADD 23.10, PolyPhen-2 0.57
- G30A (p.Gly30Ala), gnomAD 15-71810832-G-C, CADD 16.80, PolyPhen-2 0.22
- G30G (p.Gly30Gly), rs1204872132, gnomAD 15-71810833-C-A, CADD 8.68
- R31G (p.Arg31Gly), rs2543252229, ClinGen CA393031750, ClinVar RCV003863574, CADD 17.50, PolyPhen-2 0.00, Uncertain significance, not provided
- R31I (p.Arg31Ile), rs2054172755, ClinGen CA393031756, ClinVar RCV002643535, ClinVar RCV004958689, CADD 22.30, PolyPhen-2 0.05, Uncertain significance, not provided; Inborn genetic diseases
- R31K (p.Arg31Lys), gnomAD 15-71810835-G-A, CADD 16.30, PolyPhen-2 0.01
- R31S (p.Arg31Ser), gnomAD 15-71810836-A-T, CADD 9.80, PolyPhen-2 0.00
- R31R (p.Arg31Arg), gnomAD 15-71810836-A-G, CADD 6.99
- W32* (p.Trp32Ter), rs2543252248, ClinVar RCV004574401, CADD 37.00, Likely pathogenic
- W32G (p.Trp32Gly), cosmic curated COSV10605, ExAC rs377300789, TOPMed rs377300789, gnomAD rs377300789, CADD 21.30, PolyPhen-2 0.00
- W32R (p.Trp32Arg), ExAC rs377300789, TOPMed rs377300789, gnomAD rs377300789, CADD 20.40, PolyPhen-2 0.09, Uncertain significance, not provided
- W32S (p.Trp32Ser), gnomAD 15-71810811-C-CCT, CADD 20.70
- W32C (p.Trp32Cys), gnomAD 15-71810839-G-T, CADD 25.80, PolyPhen-2 0.53
- G33C (p.Gly33Cys), NCI-TCGA Cosmic COSV1004, cosmic curated COSV10048, CADD 24.80, PolyPhen-2 0.89, Variant assessed as somatic; moderate impact.
- G33V (p.Gly33Val), rs2543252255, ClinGen CA393031795, ClinVar RCV003858809, CADD 18.30, PolyPhen-2 0.21, Uncertain significance, not provided
- G33A (p.Gly33Ala), gnomAD 15-71810837-TG-T, CADD 26.50
- G33R (p.Gly33Arg), gnomAD 15-71810840-G-C, CADD 24.30, PolyPhen-2 0.74
- G33D (p.Gly33Asp), gnomAD 15-71810841-G-A, CADD 15.00, PolyPhen-2 0.14
- G33G (p.Gly33Gly), gnomAD 15-71810842-C-T, CADD 9.16
- L34V (p.Leu34Val), Ensembl rs898942829, CADD 16.40, PolyPhen-2 0.00, Uncertain significance, Inborn genetic diseases
- L34M (p.Leu34Met), gnomAD 15-71810843-C-A, CADD 21.80, PolyPhen-2 0.12
- L34Q (p.Leu34Gln), gnomAD 15-71810844-T-A, CADD 20.80, PolyPhen-2 0.01
- L34P (p.Leu34Pro), gnomAD 15-71810844-T-C, CADD 17.50, PolyPhen-2 0.00
- L34R (p.Leu34Arg), gnomAD 15-71810844-T-G, CADD 21.20, PolyPhen-2 0.00
- L34L (p.Leu34Leu), gnomAD 15-71810845-G-T, CADD 6.59
- G35V (p.Gly35Val), TOPMed rs1336199172, CADD 21.50, PolyPhen-2 0.03
- G35R (p.Gly35Arg), gnomAD 15-71810846-G-A, CADD 20.40, PolyPhen-2 0.37
- G35W (p.Gly35Trp), gnomAD 15-71810846-G-T, CADD 24.30, PolyPhen-2 0.71
- G35E (p.Gly35Glu), gnomAD 15-71810847-G-A, CADD 18.40, PolyPhen-2 0.16
- G35G (p.Gly35Gly), gnomAD 15-71810848-G-T, CADD 7.79
- E36Q (p.Glu36Gln), Ensembl rs1034392656
- E36R (p.Glu36Arg), NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- E36* (p.Glu36Ter), gnomAD 15-71810849-G-T, CADD 37.00
- E36G (p.Glu36Gly), gnomAD 15-71810850-A-G, CADD 24.40, PolyPhen-2 0.01
- D37G (p.Asp37Gly), Ensembl rs2140287956
- D37Y (p.Asp37Tyr), TOPMed rs2054172935, CADD 23.10, PolyPhen-2 0.01
- D37N (p.Asp37Asn), gnomAD 15-71810852-G-A, CADD 21.70, PolyPhen-2 0.06
- D37E (p.Asp37Glu), gnomAD 15-71810854-T-A, CADD 6.82, PolyPhen-2 0.00
Public NR2E3 analysis runs
- NR2E3 analysis run — NR2E3 (865 variants) — completed 2026-08-22